WATERS CORP /DE/
For the period ended Oct 3, 2026. Filed Nov 10, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Oct 3, 2026 · Filed Nov 10, 2026
What changed in Management’s Discussion and Analysis?
Read the current filingPrevious report: 10-Q
Period ended 2026-07-04; filed 2026-08-11.
0001193125-26-344691
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsCurrent report: 10-Q
Period ended 2026-10-03; filed 2026-11-10.
0001193125-26-455594
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of OperationsThe baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.
Compared 42 previous paragraphs and 100 current paragraphs.
23 unchanged; 18 reworded; 57 added; 1 removed; 0 previous and 2 current paragraphs rearranged.
Tables are not compared: 2 previous and 48 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.
A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.
Added paragraphs (57)
Current report
Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations
Current report
Operating Income (Loss)
Current report
Results of Operations
Current report
Revenues by Geography
Current report
Geographic revenue information is presented below for the three and nine months ended October 3, 2026 and September 27, 2025 (dollars in millions):
Current report
Geographically, BDS Business revenue for the third quarter and first nine months of 2026 was $185 million and $451 million in Asia, $427 million and $1.1 billion in the Americas and $284 million and $731 million in Europe, respectively. Foreign currency translation had minimal impact on BDS Business revenue in the third quarter of 2026 and increased revenue by 3% in the first nine months of 2026, respectively, since the Closing Date. Excluding the BDS Business revenue, legacy Waters revenue increased 15% and 11% in Asia, 10% and 8% in the Americas and 1% and 9% in Europe for the third quarter and first nine months of 2026, respectively, as compared to the third quarter and first nine months of 2025. This revenue growth was broad-based across all major regions, led by China and the Americas. Foreign currency translation decreased Waters legacy revenue growth by 1% and had minimal impact in the third quarter and first nine months of 2026, respectively.
Current report
Revenues by Product
Current report
Product revenue information is presented below for the three and nine months ended October 3, 2026 and September 27, 2025 (dollars in millions):
Current report
Instrument system revenue increased 54% and 49% in the third quarter and first nine months of 2026, primarily driven by the $153 million and $379 million, respectively, in instrument revenue contributed by the BDS Business. Excluding the impact of the BDS Business instrument revenue, legacy instrument revenue increased 10% and 7% in the third quarter and first nine months of 2026, respectively. This revenue growth was primarily driven by higher customer demand for our LC & MS instrument systems across most major regions. Foreign currency translation decreased legacy instrument system revenue growth by 1% in both the third quarter and first nine months of 2026.
Current report
Recurring revenues (combined sales of precision chemistry consumables and services) increased 171% and 151% for the third quarter and first nine months of 2026, respectively, primarily driven by $743 million and $1.8 billion, respectively, of revenue contributed by the BDS Business since the Closing Date. Excluding the BDS Business revenue, legacy recurring revenues increased 8% and 11%, in the third quarter and first nine months of 2026, respectively, primarily due to broad-based growth across all geographical regions. Foreign currency translation decreased recurring revenues growth by 1% in the third quarter, but had minimal impact for the first nine months of 2026, respectively. Excluding the BDS Business revenue, chemistry consumable revenue increased 10% and 12% for the third quarter and first nine months of 2026, respectively. The double-digit chemistry growth can be attributed to the uptake in columns and application-specific testing kits to pharmaceutical customers. Foreign currency translation decreased chemistry consumable revenue growth by 2% and 1% in the third quarter and first nine months of 2026, respectively. In addition, the recurring revenues growth was positively impacted by the six additional calendar days in the first nine months of 2026.
Current report
Operating Segments
Current report
As a result of the BDS Business Acquisition, the Company has reorganized itself into the following operating segments: Analytical Sciences; Materials Sciences; Biosciences and Advanced Diagnostics. For purposes of financial reporting, the Analytical Sciences (formerly Waters Division, excluding Waters Clinical business) and the Materials Sciences (formerly TA Division) operating segments have been combined into one reportable segment. Biosciences and Advanced Diagnostics each represent a reportable segment, resulting in three total reportable segments, as presented below. To conform to the current post-acquisition reporting structure, the Company has reclassified the Waters Clinical business into the Advanced Diagnostics segment for all periods presented.
Current report
Revenues by segment were as follows for the three and nine months ended October 3, 2026 and September 27, 2025 (dollars in millions):
Current report
Segment operating income (loss) were as follows for the three and nine months ended October 3, 2026 and September 27, 2025 (dollars in millions):
Current report
Corporate and other expenses consist of information technology, financing and accounting, human resources, communication and legal function costs; ERP implementation and transformation costs; restructuring costs; and BDS Business Acquisition-related costs including all incremental costs incurred to effect the BDS Business Acquisition, such as advisory, legal, accounting, tax, valuation, other professional fees, integration costs and other expenses.
Current report
Analytical & Materials Sciences
Current report
Analytical Sciences products and service revenue increased 8% and 9% in the third quarter and first nine months of 2026, with the effect of foreign currency translation decreasing sales growth by 1% in both periods. Instrument system revenue (primarily LC and MS technology-based) increased 9% and 8% in the third quarter and first nine months of 2026, respectively, primarily driven by higher customer demand for our Acquity and Xevo TQ-S instrument systems.
Current report
Analytical Sciences consumables’ revenue grew double-digits due to the continued demand across all major geographies driven by the uptake in columns and application-specific testing kits to pharmaceutical customers. Foreign currency decreased chemistry revenue growth by 2% and 1% in the third quarter and first nine months of 2026, respectively. Service revenue growth increased 6% and 10% in the third quarter and first nine months of 2026, respectively, due to higher service demand billing in most major regions. Foreign currency translation decreased service sales growth by 2% and had minimal impact in the third quarter and first nine months of 2026, respectively.
Current report
Materials Sciences revenue increased 7% and 6% in the third quarter and first nine months of 2026, respectively, which was primarily driven by customer demand for our thermal analysis and rheology instrument systems and services. Foreign currency translation decreased revenue growth by 2% and had minimal impact in the third quarter and first nine months of 2026, respectively.
Current report
The Analytical & Materials Sciences segment operating income as a percentage of revenues decreased in the third quarter and first nine months of 2026 as compared to the third quarter and first nine months of 2025 as a result of the higher sales volumes being offset by the impact of foreign currency translation, sales mix, merit compensation costs and additional new product development costs.
Current report
Biosciences
Current report
The Biosciences revenues of $396 million and $996 million in the third quarter and first nine months of 2026, respectively, includes only revenue from the Closing Date through the end of the reporting period. The Biosciences cost of revenue was $167 million and $411 million and operating costs were $85 million and $233 million, for the third quarter and first nine months of 2026, respectively.
Current report
Advanced Diagnostics
Current report
The Advanced Diagnostic Solutions revenues of $575 million and $1.4 billion in the third quarter and first nine months of 2026, respectively, includes $75 million and $208 million of total revenue attributed to the Waters Clinical Business in the third quarter and first nine months of 2026, respectively, which was recast into the Advanced Diagnostics segment. The remaining revenue for 2026 is attributed to BDS Business revenue from the Closing Date through the end of the reporting period.
Current report
The Advanced Diagnostics segment operating income as a percentage of revenue in the third quarter and first nine months of 2026 was 26.4% and 23.6%, respectively. Advanced Diagnostics cost of revenue was $307 million and $790 million and operating costs were $116 million and $314 million for the third quarter and first nine months of 2026, respectively.
Current report
Liquidity and Capital Resources
Current report
Condensed Consolidated Statements of Cash Flows (in millions):
Current report
Cash Flow from Operating Activities
Current report
Net cash provided by operating activities was $315 million and $488 million during the first nine months of 2026 and 2025, respectively. The decrease in 2026 operating cash flow was primarily caused by the BDS Business Acquisition. This decrease in operating cash flow can be attributed to the $142 million of payments made in connection with BDS Business acquisition transaction closing; integration and transformation costs as well as $46 million of restructuring payments made during the first nine months of 2026. The changes within net cash provided by operating activities include the following significant changes in the sources and uses of net cash provided by operating activities, aside from the changes in net income:
Current report
Cash Flow from Investing Activities
Current report
Net cash used in investing activities totaled $16 million and $110 million during the first nine months of 2026 and 2025, respectively. The 2026 investing activities were impacted by the $85 million of net cash acquired from the BDS Business Acquisition and the 2025 investing activities were impacted by the $35 million of cash used to complete the acquisition of Halo Labs. Additions to fixed assets and capitalized software were $150 million and $74 million in the first nine months of 2026 and 2025, respectively.
Current report
Cash Flow from Financing Activities
Current report
As of October 3, 2026, the Company had a total of $5.1 billion in outstanding debt, which consisted of $0.7 billion in outstanding senior unsecured notes, $3.5 billion in outstanding Senior Notes, $0.4 billion borrowed under the SpinCo Credit Agreement and $0.5 billion borrowed under the credit agreement governing its $1.8 billion revolving credit facility. The Company’s net debt borrowings decreased by $253 million during the first nine months of 2026, which reflects the proceeds from debt issuances of $4.1 billion and payments on debt of $4.3 billion, respectively, primarily related to the funding of the BDS Business Acquisition.
Current report
On March 23, 2026, SpinCo issued Senior Notes in the aggregate principal amount of $3.5 billion. The obligations of SpinCo under the Senior Notes are fully and unconditionally guaranteed on a senior unsecured basis by the Company and certain subsidiaries of the Company, which also guarantee the Company’s existing credit facilities. Net proceeds from the offering of the Senior Notes, together with cash on hand, were used by the Company to repay $3.5 billion of indebtedness outstanding under the SpinCo Delayed Draw Term Loan. The Senior Notes require payment of principal at maturity and interest semi-annually in cash and in arrears on March 23 and September 23 of each year, commencing on September 23, 2026.
Current report
As of October 3, 2026, the Company had entered into interest rate cross-currency swap derivative agreements with durations up to three years with an aggregate notional value of $1.3 billion to hedge the variability in the movement of foreign currency exchange rates on a portion of its euro-denominated andyen-denominated net asset investments. As a result of entering into these agreements, the Company lowered net interest expense by approximately $12 million and $8 million in first nine months of 2026 and 2025, respectively. The Company anticipates that these swap agreements will lower net interest expense by approximately $16 million in 2026.
Current report
In December 2024, the Company’s Board of Directors authorized the extension of its existing share repurchase program through January 21, 2028. The Company’s remaining authorization is $1.0 billion. The Company did not make any open market share repurchases in 2026 or 2025. The Company repurchased $15 million of common stock related to the vesting of restricted stock units during both the first nine months of 2026 and 2025.
Current report
Additionally, the Company received $26 million and $16 million of proceeds from the exercise of stock options and the purchase of shares pursuant to the Company’s employee stock purchase plan during the first nine months of 2026 and 2025, respectively.
Current report
The Company had cash, cash equivalents and investments of $593 million as of October 3, 2026. The majority of the Company’s cash and cash equivalents are generated from foreign operations, with $557 million held by foreign subsidiaries as of October 3, 2026, of which $380 million was held in currencies other than U.S. dollars.
Current report
In connection with the BDS Business Acquisition, the Company issued 38,542 thousand shares of the Company’s common stock to BD shareholders with an approximate fair value of $12.8 billion, which is presented as an adjustment to reconcile net income in the consolidated statement of cash flows for the first nine months of 2026.
Current report
Guarantor Financial Information
Showing the first 40 of 57 passages. Open the source sections for the rest.
Removed paragraphs (1)
Previous report
Operating (Loss) Income
Reworded paragraphs (18)
Previous wording
The Company’s operating results are as follows for the three and six months ended July 4, 2026 and June 28, 2025 (dollars in millions, except per share data):
Current wording
The Company’s operating results are as follows for the three and nine months ended October 3, 2026 and September 27, 2025 (dollars in millions, except per share data):
Previous wording
The Company’s revenue increased 113% in the second quarter of 2026, as compared to the second quarter of 2025 and 103% for the first half of 2026 as compared to the first half of 2025, primarily driven by $817 million and $1.3 billion of revenue contributed by the BDS Business for the second quarter and since the Closing Date for the first half of 2026, respectively. Excluding the BDS Business revenue, legacy revenue increased 7% and 10% in the second quarter and first half of 2026, respectively, primarily due to broad-based growth across all product lines and geographical regions. Foreign currency translation decreased total revenue growth by 2% for the second quarter of 2026 and had a minimal impact on total revenue growth for the first half of 2026. In addition, the first half of 2026 had six more calendar days compared to the first half of 2025.
Current wording
The Company’s revenue increased 121% in the third quarter of 2026, as compared to the third quarter of 2025 and 110% for the first nine months of 2026 as compared to the first nine months of 2025, primarily driven by $896 million and $2.2 billion of revenue contributed by the BDS Business for the third quarter and since the Closing Date for the first nine months of 2026, respectively. Excluding the BDS Business revenue, legacy revenue increased 9% and 10% in the third quarter and first nine months of 2026, respectively, primarily due to broad-based growth across all product lines and geographical regions. Foreign currency translation decreased total revenue growth by 1% for the third quarter of 2026 and had a minimal impact on total revenue growth for the first nine months of 2026. In addition, the first nine months of 2026 had six more calendar days compared to the first nine months of 2025.
Previous wording
The cost of revenue in the second quarter and first half of 2026 increased 184% and 166%, respectively, as compared to 2025. This increase is primarily attributed to the $560 million for the second quarter and $921 million for the first half of 2026 of cost of revenue from the BDS Business since the Closing Date as well as the increase in legacy business sales volume. The cost of revenue in the second quarter and first half of 2026 included $154 million and $253 million, respectively, of fair value inventory and fixed asset step-up expense recognized as a result of the BDS Business Acquisition.
Current wording
The cost of revenue in the third quarter and first nine months of 2026 increased 168% and 167%, respectively, as compared to 2025. This increase is primarily attributed to the $518 million for the third quarter and $1.4 billion for the first nine months of 2026 of cost of revenue from the BDS Business since the Closing Date as well as the increase in legacy business sales volume. The cost of revenue in the third quarter and first nine months of 2026 included $80 million and $333 million, respectively, of fair value inventory and fixed asset step-up expense recognized as a result of the BDS Business Acquisition.
Previous wording
Cost of revenue is affected by many factors, including, but not limited to, foreign currency translation, product mix, product costs of instrument systems and amortization of software platforms. At current foreign currency exchange rates, the Company expects foreign currency translation to be neutral to gross profit during 2026.
Current wording
Cost of revenue is affected by many factors, including, but not limited to, foreign currency translation, product mix, product costs of instrument systems and amortization of software platforms.
Previous wording
Selling and administrative expenses increased 105% and 111% in the second quarter and first half of 2026, respectively, as compared to 2025. The BDS Business increased selling and administrative expenses by $125 million and $224 million in the second quarter and first half of 2026, respectively, since the Closing Date. The remaining increase in selling and administrative expenses is primarily due to an increase in costs associated with merit compensation for the Company’s employees as well as $37 million and $119 million of transaction, integration and other internal costs associated with the BDS Business in the second quarter and first half of 2026, respectively.
Current wording
Selling and administrative expenses increased 86% and 103% in the third quarter and first nine months of 2026, respectively, as compared to 2025. The BDS Business increased selling and administrative expenses by $150 million and $375 million in the third quarter and first nine months of 2026, respectively, since the Closing Date. The remaining increase in selling and administrative expenses is primarily due to an increase in costs associated with merit compensation for the Company’s employees as well as $35 million and $155 million of transaction, integration and other internal costs associated with the BDS Business in the third quarter and first nine months of 2026, respectively.
Previous wording
Research and development expenses increased 149% and 129% in the second quarter and first half of 2026, respectively, as compared to 2025. The BDS Business increased research and development expenses by $66 million and $108 million in the second quarter and first half of 2026, respectively, since the Closing Date. The remaining increase in research and development expenses can be attributed to increases from costs associated with merit compensation to the Company’s employees and costs associated with new products and the development of new technology initiatives. In the second quarter and first half of 2026, research and development expenses included $1 million and $2 million, respectively, of transaction, integration and other internal costs associated with the BDS Business.
Current wording
Research and development expenses increased 96% and 117% in the third quarter and first nine months of 2026, respectively, as compared to 2025. The BDS Business increased research and development expenses by $46 million and $154 million in the third quarter and first nine months of 2026, respectively, since the Closing Date. The remaining increase in research and development expenses can be attributed to increases from costs associated with merit compensation to the Company’s employees and costs associated with new products and the development of new technology initiatives.
Previous wording
Purchased intangibles amortization increased $232 million and $372 million in the second quarter and first half of 2026, respectively, as compared to 2025 due to the BDS Business Acquisition.
Current wording
Purchased intangibles amortization increased $232 million and $604 million in the third quarter and first nine months of 2026, respectively, as compared to 2025 due to the BDS Business Acquisition.
Previous wording
In the second quarter and first half of 2026, the Company implemented a reduction in workforce that impacted approximately 3% of the Company’s employees. As a result, the Company incurred approximately $49 million and $52 million of severance-related costs for the second quarter and first half of 2026, respectively. During these periods, the Company paid $21 million and $23 million of severance-related costs in connection with the workforce reduction for the second quarter and first half of 2026, respectively. The accrued restructuring expense was approximately $29 million at July 4, 2026. This reduction in workforce will provide the Company with annual salary-related cost savings of approximately $120 million. The salary related cost savings achieved through the end of the second quarter 2026 was $14 million with the cost savings estimated to be approximately $67 million in 2026.
Current wording
In the second quarter of 2026, the Company implemented a reduction in workforce that impacted approximately 3% of the Company’s employees. As a result, the Company incurred approximately $12 million and $64 million of severance-related costs for the third quarter and first nine months of 2026, respectively. During these periods, the Company paid $23 million and $46 million of severance-related costs in connection with the workforce reduction for the third quarter and first nine months of 2026, respectively. The accrued restructuring expense was approximately $18 million at October 3, 2026. This reduction in workforce will provide the Company with annual salary-related cost savings of approximately $120 million. The salary related cost savings achieved through the end of the third quarter of 2026 was $39 million with the cost savings estimated to be approximately $67 million in 2026.
Previous wording
Operating loss was $86 million and $134 million for the second quarter and first half of 2026, respectively, a decrease of $274 million and $474 million as compared to $188 million and $340 million of operating income in the second quarter and first half of 2025, respectively. These decreases were primarily due to the impact of the higher sales volume from the legacy business and the BDS Business revenue since the Closing Date, being offset by $253 million of acquisition-related inventory and fixed asset fair value step-up expense in the first half of 2026 and $232 million and $372 million of purchased intangibles amortization related to the BDS Business in the second quarter and first half of 2026, respectively. In addition, the second quarter and first half of 2026 operating losses were impacted by $39 million and $121 million, respectively, of transaction, integration and other internal costs associated with the BDS Business Acquisition, $49 million and $52 million, respectively, of severance-related costs associated with a workforce reduction and $9 million and $18 million, respectively, of expenses associated with the Company’s new ERP system implementation.
Current wording
Operating income was $128 million and operating loss was $6 million for the third quarter and first nine months of 2026, respectively, a decrease of $64 million and $538 million as compared to $192 million and $532 million of operating income in the third quarter and first nine months of 2025, respectively. These decreases were primarily due to the impact of the higher sales volume from the legacy business and the BDS Business revenue since the Closing Date, being offset by $333 million of acquisition-related inventory and fixed asset fair value step-up expense in the first nine months of 2026 and $232 million and $604 million of purchased intangibles amortization related to the BDS Business in the third quarter and first nine months of 2026, respectively. In addition, operating income for the third quarter and operating loss for the first nine months of 2026 were impacted by $54 million and $176 million, respectively, of transaction, integration and other internal costs associated with the BDS Business Acquisition, $12 million and $64 million, respectively, of severance-related costs associated with a workforce reduction and $7 million and $25 million, respectively, of expenses associated with the Company’s new ERP system implementation.
Previous wording
In the second quarter and first half of 2026, the Company’s interest expense increased $45 million and $80 million, respectively, which can be primarily attributed to the financing costs incurred by the Company related to the funding of the BDS Business Acquisition.
Current wording
In the third quarter and first nine months of 2026, the Company’s interest expense, net increased $31 million and $108 million, respectively, which can be primarily attributed to the financing costs incurred by the Company related to the funding of the BDS Business Acquisition.
Previous wording
The Company’s effective tax rates for the second quarter and first half of 2026 were 3.5% and 9.2%, respectively, compared to 17.2% and 16.2% for the second quarter and first half of 2025, respectively. The change between the effective tax rates can primarily be attributed to the impact of discrete tax benefits, primarily transaction and restructuring costs, in the current period and differences in the proportionate amounts ofpre-tax income, due to the BDS Business Acquisition, recognized in jurisdictions with different effective tax rates.
Current wording
The Company’s effective tax rates for the third quarter and first nine months of 2026 were (9.6%) and 18.3%, respectively, compared to 12.5% and 14.9% for the third quarter and first nine months of 2025, respectively. The change between the effective tax rates can primarily be attributed to the impact of discrete tax benefits, primarily transaction and restructuring costs, in the current period and differences in the proportionate amounts ofpre-tax income, due to the BDS Business Acquisition, recognized in jurisdictions with different effective tax rates.
Previous wording
Effective in 2024, various foreign jurisdictions began implementing aspects of the guidance issued by the Organization for Economic Co-operation and Development related to the new Pillar Two system of global minimum tax rules. These changes in tax law did not have a material impact on the Company’s financial position, results of operations and cash flows for the first half of 2026. The Company continues to monitor the adoption of the Pillar Two rules in additional jurisdictions.
Current wording
Effective in 2024, various foreign jurisdictions began implementing aspects of the guidance issued by the Organization for Economic Co-operation and Development related to the new Pillar Two system of global minimum tax rules. These changes in tax law did not have a material impact on the Company’s financial position, results of operations and cash flows for the first nine months of 2026. The Company continues to monitor the adoption of the Pillar Two rules in additional jurisdictions.
Previous wording
Net (Loss) Income per Diluted Common Share
Current wording
Net Income (Loss) per Diluted Common Share
Previous wording
The decline in the net loss per diluted common share to $1.39 and $2.31 in the second quarter and first half of 2026, respectively, as compared to the $2.47 and $4.50 of net income per diluted common share in the second quarter and first half of 2025, respectively, is attributed to the following BDS Business Acquisition-related items: purchase accounting fair value step-up expense, increases in purchased intangibles amortization expense, restructuring charges, increase in interest expense, and various transaction, integration and other internal costs.
Current wording
The decline in the net income per diluted common share to $0.82 in the third quarter and to a net loss per diluted common share of $1.37 in the first nine months of 2026, respectively, as compared to the $2.50 and $7.00 of net income per diluted common share in the third quarter and first nine months of 2025, respectively, is attributed to the following BDS Business Acquisition-related items: purchase accounting fair value step-up expense, increases in purchased intangibles amortization expense, restructuring charges, increase in interest expense, and various transaction, integration and other internal costs.
Previous wording
Net cash provided by operating activities was $198 million, compared to net cash provided by operating activities of $301 million in the first half of 2026 and 2025, respectively. The decline is primarily attributable to the net $157 million receivable due from BD, relating to net cash settlement for activity since the Closing Date, and $105 million of payments made in connection with transaction and integration costs associated with the BDS Business Acquisition.
Current wording
Net cash provided by operating activities was $315 million, compared to net cash provided by operating activities of $488 million in the first nine months of 2026 and 2025, respectively. The decline is primarily attributable to the $142 million of payments made in connection with transaction and integration costs associated with the BDS Business Acquisition and $46 million of restructuring related payments for the nine months ended October 3, 2026.
Previous wording
Net cash provided by (used in) investing activities included capital expenditures related to property, plant, equipment and software capitalization of $87 million in the first half of 2026 as compared to the $48 million of net cash used in investing activities in the first half of 2025. The 2026 investing activities were impacted by the $144 million of cash acquired from the BDS Business Acquisition.
Current wording
Net cash provided by investing activities included capital expenditures related to property, plant, equipment and software capitalization of $150 million in the first nine months of 2026 as compared to the $74 million of capital expenditures in the first nine months of 2025. The 2026 investing activities were impacted by the $85 million of net cash acquired from the BDS Business Acquisition, which was net of the $59 million final closing statement payment in the quarter related to the BDS Acquisition.
Previous wording
On March 23, 2026, SpinCo issued senior notes (the “Senior Notes”) in the aggregate principal amount of $3.5 billion. Net proceeds from the offering of the Senior Notes, together with cash on hand, were used by the Company to repay $3.5 billion of indebtedness outstanding under the SpinCo Delayed Draw Term Loan.
Current wording
On March 23, 2026, SpinCo issued senior notes (the “Senior Notes”) in the aggregate principal amount of $3.5 billion. Net proceeds from the offering of the Senior Notes, together with cash on hand, were used by the Company to repay $3.5 billion of indebtedness outstanding under the SpinCo Delayed Draw Term Loan. As of October 3, 2026 the Company had $650 million of Senior Notes that will mature in September 2027. The Company has sufficient capital to fund this payment through cash on hand and borrowing capacity under its existing credit facility.
Previous wording
As part of the BDS Business Acquisition, a portion of the total consideration paid was reflected as a deposit asset on the opening balance sheet, which is attributable to the Company’s present right to the future economic benefits of the business in those foreign jurisdictions where legal and beneficial title had not transferred to the Company as of February 9, 2026. Changes in the deposit asset are driven by changes in the underlying assets and liabilities in those foreign jurisdictions, and the cash payments (or cash receipts) resulting from the changes in these assets are classified as investing cash flows. The change in the deposit asset of $51 million in the first half of 2026 is primarily related to the collection of third-party customer receivables that existed as of February 9, 2026.
Current wording
As part of the BDS Business Acquisition, a portion of the total consideration paid was reflected as a deposit asset on the opening balance sheet, which is attributable to the Company’s present right to the future economic benefits of the business in those foreign jurisdictions where legal and beneficial title had not transferred to the Company as of February 9, 2026. Changes in the deposit asset are driven by changes in the underlying assets and liabilities in those foreign jurisdictions, and the cash payments (or cash receipts) resulting from the changes in these assets are classified as investing cash flows. The change in the deposit asset of $59 million in the first nine months of 2026 is primarily related to the collection of third-party customer receivables that existed as of February 9, 2026.
Rearranged current paragraphs (2)
Current report — wording carried from elsewhere
As part of the BDS Business Acquisition, a portion of the total consideration paid was reflected as a deposit asset on the opening balance sheet. Changes in the deposit asset are driven by changes in the underlying assets and liabilities in those foreign jurisdictions. The change in the deposit asset of $59 million in the first nine months of 2026 is primarily related to the collection of third-party customer receivables that existed as of February 9, 2026.
Current report — wording carried from elsewhere
On January 8, 2026, SpinCo entered into the SpinCo Credit Agreement. On February 6, 2026, SpinCo borrowed $4.0 billion of unsecured term loans under the SpinCo Credit Agreement, consisting of a $3.5 billion tranche which will mature and be payable in full 364 days after the Funding Date and a $500 million tranche which will mature and be payable in full on the second anniversary of the Funding Date, and such funds were used by SpinCo on the Funding Date to finance the SpinCo Cash Distribution. Upon consummation of the BDS Business Acquisition, all of this indebtedness was assumed by the Company. The $3.5 billion of proceeds from the Senior Notes were used by the Company to repay the $3.5 billion principal balance on the SpinCo Delayed Draw Term Loan in March 2026. The SpinCo Term Loan has a maturity date of February 4, 2028.